SEC 13F Intelligence

Highvista Strategies LLC / GPCR

Highvista Strategies LLC’s Structure Therapeutics Inc Position

Does Highvista Strategies LLC own Structure Therapeutics Inc (GPCR)? Yes — 123.9K shares worth $6M (+1.65% of its 13F portfolio) as of Q1 2026, down from 193.0K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
123.9K
% of Portfolio
+1.65%
Quarters Held
11
currently held

Position History GPCR

Reported value by quarter
Q3 ’23: $4MQ3 ’23Q4 ’23: $3MQ1 ’24: $2MQ1 ’24Q2 ’24: $1MQ3 ’24: $1MQ3 ’24Q4 ’24: $476,254Q1 ’25: $303,981Q1 ’25Q2 ’25: $2MQ3 ’25: $7MQ3 ’25Q4 ’25: $13MQ1 ’26: $6MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026123.9K$6M+1.65%
Q4 2025193.0K$13M+3.46%
Q3 2025236.2K$7M+1.62%
Q2 202586.6K$2M+0.66%
Q1 202517.6K$303,981+0.12%
Q4 202417.6K$476,254+0.18%
Q3 202431.7K$1M+0.48%
Q2 202435.1K$1M+0.50%
Q1 202437.4K$2M+0.57%
Q4 202374.8K$3M+1.11%
Q3 202374.8K$4M+1.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of GPCR.